Role of serum Nogo-B as a biomarker for diagnosis of chronic liver diseases and its severity
Open Access
- 20 August 2021
- journal article
- research article
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 11 (1) , 1-7
Abstract
Background: Nogo-B is one of the members of the reticulon family. Nogo-B influences the proliferation of the hepatic stellate cells inducing liver fibrotic changes. We aimed at measuring the serum levels of Nogo-B in patients with chronic liver disease (CLD) with different etiologies. Ninety subjects were included, 18 of them were normal healthy individuals and 72 had liver disease (fibrosis/cirrhosis) with different etiologies: post-hepatitis C infection, post-hepatitis B infection, NASH, and autoimmune hepatitis. Serum Nogo-B was assessed using ELISA. Patients were subdivided according to the Child-Pugh score into 3 groups: group 1—Child A (24 patients); group 2—Child B (24 patients); and group 3—Child C (24 patients). Results: Serum Nogo-B levels were found to be significantly higher in patients (1477.92 ± 1113.50) when compared with healthy control (301.28 ± 180.87) (p < 0.001). There was a statistically significant difference in serum Nogo-B level between the three sub-groups of patients (p < 0.001). A positive correlation was found between serum Nogo-B and MELD score (r = 0.46, p-value < 0.001). However, there was no correlation found between Nogo-B and FIB-4 index or APRI score. There was a significant positive correlation between serum Nogo-B level and coagulation profile and serum bilirubin. An inverse correlation was found between serum Nogo-B with serum albumin. A ROC curve was done to examine the validity of Nogo-B in the diagnosis of liver cirrhosis, and the area under the curve was found to be 0.979, a cutoff value of 600 with a sensitivity of 97.2% and a specificity of 94.4% (p-value < 0.001). Conclusion: Nogo-B had a high value in the identification of patients with any severity of CLD. There is a highly significant correlation between Nogo-B and the synthetic function of the liver; it could be used as a measure of hepatic functional reserve.Keywords
This publication has 15 references indexed in Scilit:
- Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in miceHepatology, 2013
- Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosisHepatology, 2011
- Liver Regeneration after Partial HepatectomyThe American Journal of Pathology, 2010
- Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repairProceedings of the National Academy of Sciences, 2009
- Cell autonomous function of nogo and reticulons: The emerging story at the endoplasmic reticulumJournal of Cellular Physiology, 2008
- The reticulons: a family of proteins with diverse functionsGenome Biology, 2007
- Adenosine A2Areceptors play a role in the pathogenesis of hepatic cirrhosisBritish Journal of Pharmacology, 2006
- Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infectionsJournal of Hepatology, 2006
- Reticulon 3 is involved in membrane trafficking between the endoplasmic reticulum and GolgiBiochemical and Biophysical Research Communications, 2005
- Nogo and its paRTNersTrends in Cell Biology, 2003